Full View

Validation of the IMPROVE‐DD risk assessment model for venous thromboembolism among hospitalized patients with COVID‐19

AC Spyropoulos, SL Cohen, E Gianos… - … and practice in …, 2021 - Wiley Online Library
Background Antithrombotic guidance statements for hospitalized patients with coronavirus
disease 2019 (COVID‐19) suggest a universal thromboprophylactic strategy with potential to …
被引用次数：42 相关文章

Validation of the IMPROVE‐DD risk assessment model for venous thromboembolism among hospitalized patients with COVID‐19.

AC Spyropoulos, SL Cohen, E Gianos… - Research and Practice …, 2021 - go.gale.com
Background: Antithrombotic guidance statements for hospitalized patients with coronavirus
disease 2019 (COVID‐19) suggest a universal thromboprophylactic strategy with potential to …
[HTML] sciencedirect.com

[HTML][HTML] Validation of the IMPROVE‐DD risk assessment model for venous thromboembolism among hospitalized patients with COVID‐19

AC Spyropoulos, SL Cohen, E Gianos, N Kohn… - Research and Practice …, 2021 - Elsevier
Background Antithrombotic guidance statements for hospitalized patients with coronavirus
disease 2019 (COVID‐19) suggest a universal thromboprophylactic strategy with potential to …
[HTML] rpthjournal.org

[HTML][HTML] Validation of the IMPROVE‐DD risk assessment model for venous thromboembolism among hospitalized patients with COVID‐19

AC Spyropoulos, SL Cohen, E Gianos… - Research and Practice …, 2021 - rpthjournal.org
Background Antithrombotic guidance statements for hospitalized patients with coronavirus
disease 2019 (COVID‐19) suggest a universal thromboprophylactic strategy with potential to …

Validation of the IMPROVE-DD risk assessment model for venous thromboembolism among hospitalized patients with COVID-19

AC Spyropoulos, SL Cohen… - … and practice in …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Antithrombotic guidance statements for hospitalized patients with coronavirus
disease 2019 (COVID-19) suggest a universal thromboprophylactic strategy with potential to …
[PDF] portailvasculaire.fr

[PDF][PDF] Validation of the IMPROVE-DD risk assessment model for venous thromboembolism among hospitalized patients with COVID-19

AC Spyropoulos, SLC MD, MD Eugenia Gianos… - 2021 - portailvasculaire.fr
Background: Antithrombotic guidance statements for hospitalized patients with coronavirus
disease 2019 (COVID-19) suggest a universal thromboprophylactic strategy with potential to …

Validation of the IMPROVE-DD risk assessment model for venous thromboembolism among hospitalized patients with COVID-19.

AC Spyropoulos, SL Cohen, E Gianos… - … and Practice in …, 2021 - europepmc.org
Background Antithrombotic guidance statements for hospitalized patients with coronavirus
disease 2019 (COVID-19) suggest a universal thromboprophylactic strategy with potential to …

Validation of the IMPROVE‐DD risk assessment model for venous thromboembolism among hospitalized patients with COVID‐19

AC Spyropoulos, SL Cohen, E Gianos… - … and Practice in …, 2021 - search.proquest.com
Background Antithrombotic guidance statements for hospitalized patients with coronavirus
disease 2019 (COVID‐19) suggest a universal thromboprophylactic strategy with potential to …
[HTML] nih.gov

[HTML][HTML] Validation of the IMPROVE‐DD risk assessment model for venous thromboembolism among hospitalized patients with COVID‐19

AC Spyropoulos, SL Cohen, E Gianos… - … and Practice in …, 2021 - ncbi.nlm.nih.gov
Background Antithrombotic guidance statements for hospitalized patients with coronavirus
disease 2019 (COVID‐19) suggest a universal thromboprophylactic strategy with potential to …

Validation of the IMPROVE-DD risk assessment model for venous thromboembolism among hospitalized patients with COVID-19

AC Spyropoulos, SL Cohen… - Res Pract …, 2021 - academicworks.medicine.hofstra …
"Validation of the IMPROVE-DD risk assessment model for venous thromboe" by AC
Spyropoulos, SL Cohen et al. Home Search Browse Collections My Account About DC …